미국 CDC가 밝힌 2021년 주요 개정사항 편집하기 (부분)

=='''Gonorrhea'''==
Antibiotic resistance remains a challenge and complicates gonococcal treatment. With the emergence of azithromycin resistance and optimization of antimicrobial stewardship, dual treatment for gonococcal infection is no longer recommended.<br>

The recommended treatment for gonococcal infection of the cervix, urethra and rectum is ceftriaxone 500 mg intramuscularly (IM) in a single dose. For patients over 150 kilograms (kg), the ceftriaxone dose should be increased to 1 g.<br>

If ceftriaxone is not available, gentamicin 240 mg IM in a single dose plus azithromycin 2 g orally in a single dose, or cefixime 800 mg orally in a single dose are both alternative regimens.<br>

If chlamydial co-infection cannot be excluded, doxycycline 100 mg orally twice daily for seven days should be added.<br>

Gonococcal pharyngeal infections are common among certain populations and can be a source of community transmission. Pharyngeal infections are more difficult to treat than genital infections.<br>

The recommended pharyngeal gonococcal treatment regimen is ceftriaxone 500 mg IM in a single dose for patients less than 150 kg and 1 g for those weighing over 150 kg. No reliable alternative treatment regimen is recommended. Any person with pharyngeal infection should return for a test of cure seven to 14 days after treatment.<br>